Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation

Tundra lists 1 Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07483385

Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation

This study is an investigator-initiated prospective, single-center, open-label clinical trial designed to evaluate the clinical efficacy and safety of Lusutrombopag in promoting platelet remodeling after allogeneic hematopoietic stem cell transplantation in patients with hematologic disorders.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-25

Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation

Hematologic Disorders